You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • THU0183 Significantly improved upper gastrointestinal (ugi) tolerability with celecoxib, a cox-2 specific inhibitor, compared with conventional nsaids. the success i trial

Citation Tools

Article menu
Download PDFPDF
Speaker abstracts 2001
Cartilage in bone biology and pathophysiology
THU0183 Significantly improved upper gastrointestinal (ugi) tolerability with celecoxib, a cox-2 specific inhibitor, compared with conventional nsaids. the success i trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Goldstein J, Agrawal N, Eisen G, et al
THU0183 Significantly improved upper gastrointestinal (ugi) tolerability with celecoxib, a cox-2 specific inhibitor, compared with conventional nsaids. the success i trial
Annals of the Rheumatic Diseases 2001;60:A427.